Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan

Clinical trial NCT02510274 · COMPLETED

Trial details

NCT number: NCT02510274
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease Hyperphosphatemia Undergoing Hemodialysis

Start date: 2014-05-12
Primary completion: 2014-11-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.